FMB
EW icon

Field & Main Bank’s Edwards Lifesciences EW Stock Holding History

Field & Main Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.8K Hold
35
– – ﹤0.01% 249
2025
Q4 		$2.98K Hold
35
– – ﹤0.01% 248
2025
Q3 		$2.72K Hold
35
– – ﹤0.01% 243
2025
Q2 		$2.74K Hold
35
– – ﹤0.01% 232
2025
Q1 		$2.54K Sell
35
-65
-65% -$4.65K ﹤0.01% 233
2024
Q4 		$7.4K Hold
100
– – ﹤0.01% 239
2024
Q3 		$6.6K Hold
100
– – ﹤0.01% 227
2024
Q2 		$9.24K Hold
100
– – ﹤0.01% 229
2024
Q1 		$9.55K Hold
100
– – ﹤0.01% 226
2023
Q4 		$7.62K Hold
100
– – ﹤0.01% 228
2023
Q3 		$6.93K Sell
100
-389
-80% -$31.3K ﹤0.01% 231
2023
Q2 		$46.1K Hold
489
– – 0.03% 179
2023
Q1 		$40.5K Sell
489
-75
-13% -$5.89K 0.02% 176
2022
Q4 		$42.1K Hold
564
– – 0.03% 174
2022
Q3 		$47K Sell
564
-103
-15% -$9.91K 0.03% 170
2022
Q2 		$63K Buy
667
+317
+91% +$32.8K 0.04% 162
2022
Q1 		$41K Hold
350
– – 0.02% 167
2021
Q4 		$45K Sell
350
-125
-26% -$14.6K 0.03% 167
2021
Q3 		$54K Buy
475
+100
+27% +$11.4K 0.04% 155
2021
Q2 		$39K Hold
375
– – 0.03% 158
2021
Q1 		$31K Hold
375
– – 0.02% 154
2020
Q4 		$34K Sell
375
-6
-2% -$498 0.03% 147
2020
Q3 		$30K Hold
381
– – 0.02% 151
2020
Q2 		$26K Buy
+381
New +$27.1K 0.02% 148
2019
Q4 		$41K Hold
531
– – 0.03% 151
2019
Q3 		$39K Hold
531
– – 0.04% 152
2019
Q2 		$33K Hold
531
– – 0.03% 161
2019
Q1 		$34K Buy
+531
New +$30.3K 0.03% 154
2018
Q3 		$37K Sell
630
-84
-12% -$4.11K 0.03% 167
2018
Q2 		$34K Buy
714
+165
+30% +$7.7K 0.03% 169
2018
Q1 		$26K Hold
549
– – 0.03% 177
2017
Q4 		$21K Buy
+549
New +$20.1K 0.02% 184

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Field & Main Bank's EW Position: Q1 2026 in Review

Field & Main Bank held its Edwards Lifesciences (EW) position steady in Q1 2026 at 35 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Field & Main Bank first reported a position in EW in Q4 2017 and has held it in 32 quarters since. The position peaked at $63K in Q2 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Field & Main Bank held 35 shares of Edwards Lifesciences worth $2.8K as of Q1 2026.
  • Field & Main Bank left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Field & Main Bank's portfolio in Q1 2026, its #249 holding.
  • Field & Main Bank first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 32 quarters since.
  • Field & Main Bank's Edwards Lifesciences position peaked at $63K in Q2 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.